FBIO
Fortress Biotech Inc Pref Series A
NASDAQ: FBIOP · HEALTHCARE · BIOTECHNOLOGY
$13.60
-0.24% today
Updated 2026-06-02
Market cap
$77.81M
P/E ratio
—
P/S ratio
1.23x
EPS (TTM)
$-0.86
Dividend yield
—
52W range
$6 – $21
Volume
0.0M
Fortress Biotech Inc Pref Series A (FBIOP) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$13.60
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$13.03
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 10.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.